Index to Volume 1, 2003 of The Carlat Report

Dr. Zimmerman, you and your colleagues have published prolifically on whether the research studies we read are truly relevant to our clinical practices. What's the bottom line of your research?

What a bind we seem to be in. On the one hand, we are short several thousand child psychiatrists in the United States, and parents are beating down our (generalist) doors to get their children medicated. On the other hand, every other piece of news about childhood psychopharmacology seems either bad or lukewarm.

Just when we thought we could finally dismiss the notion that SSRIs cause suicidal ideation, along came the Brits!

Every so often the stars align themselves in such a way that you will be referred an "easy" adolescent. This is a teenager who looks and dresses like you, who is seeking help on his or her own urging, who describes depressive or anxiety symptoms articulately, and who responds well to standard treatment.

Dr. Bostic, what are your clinical and research responsibilities?

John Watson (1878-1958) was one of the more colorful figures in the history of American psychology. The poor son of violent, drinking man in South Carolina, Watson managed to gain admission to a local college, and then studied psychology at University of Chicago.

Dr. Stephen Wieder is a child and adolescent psychiatrist in both private and consultative practice in Newburyport, MA, and has this advice for working with families of adolescents ...

If you were in TCR's editorial offices, surrounded by boxes of articles about acetylcholinesterase inhibitors (AChEI’s), you would quickly develop a sinking sensation. Not because the articles are so boring (though, in fact, they are); rather, because the pharmaceutical hype-sters are back on parade once again.

Plaques and Tangles, Amyloid deposits and Apo-E: Who can keep them straight? Unless you are a researcher, all you really need to know is how to diagnose dementia, and how to dose the acetylcholinesterase inhibitor du jour.